Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia

A technology for relieving visual fatigue and composition, which is applied in the direction of drug combination, effective ingredients of hydroxyl compounds, and pharmaceutical formulations, can solve the problems of high cost, unfavorable animal protection, and high price, and achieve good efficiency, which is conducive to large-scale production, The effect of easy operation

Active Publication Date: 2020-12-25
LIAONING QIANLIMING PHARMA GROUP
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Liaoning Qianliming Pharmaceutical (Group) Co., Ltd.’s Qianliming Eye Ointment uses a large number of precious Chinese medicinal materials such as musk, bear bile, bezoar, astragalus, pearls, and cistanche as raw materials. The cost is high, resulting in a high price
Although the invention patent application with the patent number 2003101102983 has relatively reduced the use of medicinal flavors and dosage forms and reduced costs, it still uses more expensive medicinal materials, especially traditional Chinese medicinal materials such as bear bile, which is not conducive to animal protection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia
  • Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia
  • Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Weigh 42g of myrrh, 42g of frankincense, 10g of ginseng, 10g of medlar, 10g of Cistanche, 10g of Bupleurum, 5g of astragalus, 5g of chrysanthemum, 5g of Cassia, 5g of cassia, 2.5g of artificial bezoar, 0.5g of artificial musk, and 0.5g of borneol , peppermint 2g. Grind myrrh, frankincense, artificial bezoar, artificial musk, borneol, and mint into fine powder; add ethanol solution to extract the remaining Chinese medicinal materials, filter the extract, combine the filtrate, recover ethanol, concentrate into extract, dry, and grind into fine powder. powder, combine the superfine powder of the above-mentioned medicinal materials and the superfine powder of the extract, mix well to make a mixed fine powder, and mix with 1 kg of vaseline that has been heated, sterilized, and cooled to 60° C. to obtain an eye ointment.

Embodiment 2

[0028] Weigh 42g of myrrh, 42g of frankincense, 10g of ginseng, 10g of medlar, 10g of Cistanche, 10g of Bupleurum, 5g of astragalus, 5g of chrysanthemum, 5g of Cassia, 5g of cassia, 2.5g of artificial bezoar, 0.5g of artificial musk, and 0.5g of borneol , peppermint 2g. Grind myrrh, frankincense, artificial bezoar, artificial musk, borneol, and mint into fine powder; add ethanol solution to extract the remaining Chinese medicinal materials, filter the extract, combine the filtrate, recover ethanol, concentrate into extract, dry, and grind into Fine powder, combine the above-mentioned medical material ultra-fine powder and extractum ultra-fine powder, mix evenly, make mixed fine powder, add appropriate amount of acrylic resin 15kg, triethyl citrate 1.3kg to described mixed fine powder, use volume ratio 1: Soak in 25 liters of mixed solution of ethanol and acetone, dissolve at room temperature to make a yellow viscous liquid, transfer and coat with a coating machine, dry at 60°C...

Embodiment 3

[0030] Weigh 40g of myrrh, 45g of frankincense, 8g of ginseng, 12g of medlar, 8g of cistanche, 12g of Bupleurum, 6g of astragalus, 3g of chrysanthemum, 7g of Cassia, 7g of cassia, 1g of artificial bezoar, 0.2g of artificial musk, 0.6g of borneol, Mint 3g. Grind myrrh, frankincense, artificial bezoar, artificial musk, borneol, and mint into fine powder; add ethanol solution to extract the remaining Chinese medicinal materials, filter the extract, combine the filtrate, recover ethanol, concentrate into extract, dry, and grind into Fine powder, combine the above-mentioned medicinal material fine powder and extract fine powder, mix evenly, make mixed fine powder, sieve, mix with 1 kg of vaseline that has been heated, sterilized, and cooled to 60°C to obtain an eye ointment.

[0031] In order to reduce the cost of the traditional Chinese medicine composition of the present invention while ensuring the effect, the inventors conducted a large number of animal experiments and clinical...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pure traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia. The traditional Chinese medicine composition comprises raw material medicines in parts by weight of , 40-45 parts of myrrh, 40-45 parts of frankincense, 8-12 parts of ginseng, 8-12 parts of fructus lycii, 8-12 parts of cistanche, 8-12 parts of radix bupleuri, 3-7 parts of astragalus membranaceus, 3-7 parts of chrysanthemums, 3-7 parts of caulis spatholobi, 3-7 parts of semen cassiae, 1-3 parts of calculus bovis factitius, 0.1-1 part of muskone, 0.1-1 part of borneol and 1-3 parts of mint. The composition can be used for dredging meridians and collaterals of eyes, stimulating nerve endings and promoting local blood circulation, achieves the effects of nourishing muscles and optic nerves, relieving symptoms such as eye dryness, eye astringency and eye fatigue, treats both symptoms and root causes, prevents and treats myopia and does not have toxic or sideeffect. Besides, the invention further provides a dosage form and preparation method of the pure traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia, particularly a medicine film agent, so that treatment and use are convenient, the cost is reduced, operation is easy and convenient, and the pure traditional Chinese medicine composition is suitable for large-scale production.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for relieving visual fatigue and preventing and treating myopia, and belongs to the field of traditional Chinese medicine preparations. Background technique [0002] The occurrence of myopia is related to many factors such as heredity, development and environment. At present, informatization and networking have been integrated into human life. The human visual system has to receive more information, and the eyes are in a state of fatigue for a long time. In order to meet the long-term close reading and fine operation, the eyes need to be Long-term adaptive adjustment leads to a greatly increased incidence of myopia. The incidence of myopia in Chinese teenagers has reached 60-80%, and it is still increasing every year. Myopia has become one of the main lesions of visual fatigue. The distance vision after myopia can be correc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/815A61P27/10A61P27/02A61K31/045A61K35/413A61K35/55
CPCA61K31/045A61K35/413A61K35/55A61K36/233A61K36/258A61K36/287A61K36/324A61K36/328A61K36/481A61K36/482A61K36/486A61K36/534A61K36/64A61K36/815A61K2236/333A61P27/02A61P27/10A61K2300/00
Inventor 林继华
Owner LIAONING QIANLIMING PHARMA GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products